Clinical Trials Browser

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT05652335 2026-03-13

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Phase 1 Recruiting

180 enrolled

Plasma cell

Amyloidosis, Multiple Myeloma, Recurrence

NCT07081646 2026-03-13

ALACRITY

Phase 1/2 Recruiting

91 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT03431896 2026-03-12

MED-hATTR

Completed

37 enrolled

Plasma cell

Amyloidosis, Hereditary, Transthyretin-Related, Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Amyloid Neuropathies, Familial

NCT07172243 2026-02-27

BE.Amycon Biobank & Data Registry UZ Leuven

Recruiting

505 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Amyloid Neuropathies, Familial

NCT05145816 2026-02-17

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Phase 1/2 Recruiting

37 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Clinical Trials

ALANIS

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

ALACRITY

MED-hATTR

BE.Amycon Biobank & Data Registry UZ Leuven

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis